Floy
Floy
Floy uses artificial intelligence to unlock the full potential of radiological images and to maximize human health. The company augments routine imaging with diagnostic insights beyond the limits of human vision, helping clinicians detect early risk factors and make more comprehensive, objective assessments.
What we do
Floy provides AI-driven products for opportunistic screening and diagnostic assistance to support radiologists and care teams:
- Opportunistic screening: reveal hidden insights such as bone health (early osteoporosis detection), vascular status (cardiovascular risk assessment) and incidental findings.
- Diagnostic assistance: automated organ measurement with millimetre accuracy, tumor detection and longitudinal evaluation, and objective joint-status analysis.
Clinical validation & partnerships
Floy’s solutions are clinically validated and certified across Europe. Their AI models are trained on a large dataset (reported as 17 million medical examinations) and supported by an internal team of radiologists (18 internal radiologists). Over 300 radiology practices use Floy’s services, and the company maintains research partnerships with renowned institutions. Floy emphasizes safety and compliance (ISO, EU‑MDR, TÜV, GDPR).
